Aberrant expression of CR2 on the surface of B cells has been demonstrated both in mouse models of the disease (17, 18) and SLE patients (19, 20), which functionally contributes to B cell autoreactivity and autoimmune disease susceptibility (21–23). Here, CR2 is linked to autoimmune disease.